AMPK activation: a therapeutic target for type 2 diabetes?
Kimberly A Coughlan, Rudy J Valentine, Neil B Ruderman, Asish K Saha Endocrinology and Diabetes, Department of Medicine, Boston University Medical Center, Boston, MA, USA Abstract: Type 2 diabetes (T2D) is a metabolic disease characterized by insulin resistance, β-cell dysfunction, and el...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-06-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
Online Access: | http://www.dovepress.com/ampk-activation-a-therapeutic-target-for-type-2-diabetes-a17323 |